Jul 23, 2026
Insilico CEO Says AI Cuts Time to Drug Candidate to About One Year in China
Insilico Medicine CEO Alex Zhavoronkov told Reuters that the company typically reaches a developmental drug candidate in 13 months, with a record of nine months, by combining AI with its research operations in China. Reuters reported that China has become a major hub for next-generation medicine development, aided by lower research costs and streamlined regulation.
6 sources
00